|
NIMH-funded antidepression drug efficacy / safety studies_What do they prove? |
|
|
|
|
Monday, 02 January 2006 |
Two studies purporting to report “new encouraging” findings about the efficacy and safety of antidepressants were published on Sunday by The American Journal of Psychiatry with an accompanying editorial by Dr. Thomas Insel, director of these studies’ funding agency, the National Institute of Mental Health. |
|
Read more...
|
|
|
38 Senators--$13.4 mill pharma stock waive liability |
|
|
|
|
Thursday, 22 December 2005 |
On Tuesday evening, 38 U.S. Senators with about $13.4 million in pharmaceuticaql stock holdings approved a sweetheart deal absolving the drug / vaccine industry from liability . |
|
Read more...
|
|
|
Drugs, Devices & Doctors - NYT Paul Krugman |
|
|
|
|
Friday, 16 December 2005 |
|
New York Times columnist, Paul Krugman, got it right! The real story behind the crisis at Merck, the Cleveland Clinic, and the medical industrial complex as a whole "is bigger than either the company or the clinic. It's the story of how growing conflicts of interest may be distorting both medical research and health care in general." |
|
Read more...
|
|
|
Depression-Serotonin: How Did So Many Smart People Get it So Wrong?_WSJ |
|
|
|
|
Saturday, 19 November 2005 |
|
"Serotonin and depression: A disconnect between the advertisements and the scientific literature." "Some 19 million people in the U.S. suffer from depression in any given year. For many, SSRIs help little, if at all. To do better, we have to get the science right." Sharon Begley, Wall Street Journal
|
|
Read more...
|
|
|
Scott Gottlieb ties to drug firms |
|
|
|
|
Saturday, 12 November 2005 |
|
Dr. Scott Gottlieb's ties to drug firms spark questions over agency hiring policies |
|
Read more...
|
|
|
|
<< Start < Prev 11 12 13 Next > End >>
|
| Results 109 - 115 of 115 |